(Q31925006)

5 July 2017

title

Telithromycin (English)

1 reference

5 July 2017

J A Balfour

1

1 reference

5 July 2017

D P Figgitt

series ordinal

2

1 reference

5 July 2017

publication date

1 January 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

61

1 reference

5 July 2017

issue

6

1 reference

5 July 2017

page(s)

815-29; discussion 830-1

1 reference

In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

5 July 2017

cites work

1 reference

12 December 2020

Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia

1 reference

12 December 2020

Ketolides lack inducibility properties of MLS(B) resistance phenotype

1 reference

12 December 2020

Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status

1 reference

12 December 2020

In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniae

1 reference

12 December 2020

In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae

1 reference

12 December 2020

In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4

1 reference

12 December 2020

In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.

1 reference

12 December 2020

Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect

1 reference

12 December 2020

The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

1 reference

12 December 2020

Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies

1 reference

12 December 2020

Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia

1 reference

12 December 2020

Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia

1 reference

12 December 2020

New research in macrolides and ketolides since 1997.

1 reference

12 December 2020

In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan

1 reference

12 December 2020

Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

1 reference

12 December 2020

Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora

1 reference

12 December 2020

Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics.

1 reference

12 December 2020

Recent developments in macrolides and ketolides

1 reference

12 December 2020

Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA

1 reference

12 December 2020

Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin

1 reference

12 December 2020

Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila

1 reference

12 December 2020

In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae

1 reference

12 December 2020

Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.

1 reference

12 December 2020

In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.

1 reference

12 December 2020

Susceptibilities of Legionella spp. to newer antimicrobials in vitro

1 reference

12 December 2020

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents

1 reference

12 December 2020

Antimicrobial activity of RU-66647, a new ketolide

1 reference

12 December 2020

HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay

1 reference

12 December 2020

Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).

1 reference

12 December 2020

In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci

1 reference

12 December 2020

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

1 reference

12 December 2020

The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells

1 reference

12 December 2020

In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.

1 reference

12 December 2020

Ketolide treatment of Haemophilus influenzae experimental pneumonia

1 reference

12 December 2020

Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004

1 reference

12 December 2020

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses

1 reference

12 December 2020

Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens

1 reference

12 December 2020

10.2165/00003495-200161060-00016

Identifiers

DOI

1 reference

Dimensions Publication ID

5 July 2017

1016880263

0 references

1 reference